Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 41.00%596.81M | 50.59%1.02B | 41.49%683.04M | 41.34%423.26M | 45.21%677.79M | --482.73M | --299.46M | 170.06%466.78M | --172.84M |
| Operating income | 41.00%596.81M | 50.59%1.02B | 41.49%683.04M | 41.34%423.26M | 45.21%677.79M | 482.73M | 299.46M | 170.06%466.78M | 172.84M |
| Cost of sales | -19.76%-292.89M | -4.97%-503.98M | -4.37%-366.98M | -8.95%-244.56M | -35.36%-480.12M | ---351.6M | ---224.47M | -177.03%-354.71M | ---128.04M |
| Operating expenses | -19.76%-292.89M | -4.97%-503.98M | -4.37%-366.98M | -8.95%-244.56M | -35.36%-480.12M | -351.6M | -224.47M | -177.03%-354.71M | -128.04M |
| Gross profit | 70.08%303.93M | 161.39%516.69M | 141.02%316.06M | 138.28%178.7M | 76.38%197.67M | 131.13M | 75M | 150.14%112.07M | 44.8M |
| Selling expenses | 74.67%-797K | -71.91%-5.49M | -98.37%-4.27M | -178.16%-3.15M | -71.39%-3.19M | ---2.15M | ---1.13M | -1,593.64%-1.86M | ---110K |
| Administrative expenses | -5.63%-13.44M | -55.71%-28.25M | -63.19%-20.46M | -54.28%-12.72M | -23.18%-18.14M | ---12.54M | ---8.24M | -57.04%-14.73M | ---9.38M |
| Impairment and provision | -171.79%-201K | 197.12%708K | 306.31%425K | 134.27%280K | -24,400.00%-729K | ---206K | ---817K | 100.69%3K | ---432K |
| -Other impairment is provision | -171.79%-201K | 197.12%708K | 306.31%425K | 134.27%280K | -24,400.00%-729K | ---206K | ---817K | 100.69%3K | ---432K |
| Special items of operating profit | -26.75%8.16M | 48.43%17.05M | -67.49%3.31M | 52.71%11.14M | 50.11%11.49M | --10.17M | --7.3M | 12.91%7.65M | --6.78M |
| Operating profit | 70.81%297.66M | 167.63%500.71M | 133.43%295.05M | 141.68%174.26M | 81.41%187.09M | 126.4M | 72.1M | 147.57%103.13M | 41.66M |
| Financing cost | 0.00%-3K | -200.00%-6K | -200.00%-3K | -200.00%-3K | 0.00%-2K | ---1K | ---1K | -100.00%-2K | ---1K |
| Earning before tax | 70.82%297.66M | 167.63%500.7M | 133.43%295.05M | 141.68%174.26M | 81.41%187.09M | 126.4M | 72.1M | 147.57%103.13M | 41.66M |
| Tax | -182.74%-43.46M | -219.19%-43.3M | -220.65%-28.72M | -173.75%-15.37M | -92.67%-13.56M | ---8.96M | ---5.62M | -261.40%-7.04M | ---1.95M |
| After-tax profit from continuing operations | 59.99%254.2M | 163.60%457.41M | 126.78%266.33M | 138.97%158.88M | 80.58%173.53M | 117.44M | 66.49M | 141.98%96.09M | 39.71M |
| Earning after tax | 59.99%254.2M | 163.60%457.41M | 126.78%266.33M | 138.97%158.88M | 80.58%173.53M | 117.44M | 66.49M | 141.98%96.09M | 39.71M |
| Minority profit | -87.65%5.95M | 9.31%55.6M | 48.96%50.95M | 147.51%48.16M | 79.08%50.86M | --34.2M | --19.46M | 152.51%28.4M | --11.25M |
| Profit attributable to shareholders | 124.19%248.25M | 227.57%401.81M | 158.75%215.38M | 135.44%110.73M | 81.21%122.67M | 83.24M | 47.03M | 137.82%67.69M | 28.46M |
| Basic earnings per share | 53.33%0.46 | 168.57%0.94 | 125.00%0.54 | 0.3 | 75.00%0.35 | 0.24 | 122.22%0.2 | 0.09 | |
| Diluted earnings per share | 53.33%0.46 | 168.57%0.94 | 125.00%0.54 | 0.3 | 75.00%0.35 | 0.24 | 122.22%0.2 | 0.09 | |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PwC accounting firm | -- | -- | KPMG | -- | -- | PwC accounting firm | PwC accounting firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.